Talaris lands $100 mln Series A

Boston and Louisville-based Talaris Therapeutics Inc, a biotechnology company, has secured $100 million in Series A financing. Blackstone Life Sciences led the round with participation from Longitude Capital and Qiming Venture Partners USA.

Source: Press Release